Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
British American Tobacco has been a stalwart for investors so far this year

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
It has been a good 2025 so far for shareholders in dull defensive stocks like British American Tobacco (BATS), as markets get whipsawed one way and another by on-off tariff announcements and trade deals.
At the time of writing, BAT shares are up 430p or 15% year-to-date, on top of which the firm has paid out two dividends totalling roughly 119p, so the total return has been more like 19%, while the FTSE 100 has eked out a 5% gain.
Therefore, investors will be looking for a reassuring pre-close first-half trading update on 3 June and possibly a small increase in full-year guidance.
At the AGM in April, chairman Luc Jobin described 2025 as ‘a deployment year’ where the company builds on its investments, returning to profit growth in the U.S and gradually deploying its New Category product innovations as the year unfolds.
The key things to look for will be the outlook for total revenue, which the consensus forecasting around £26.2 billion this year, allowing for currency headwinds, and new category product revenue, which is seen around £3.9 billion against £3.4 billion last year.
Analysts and investors will also be eyeing the adjusted operating margin, which is seen flat at around 44% excluding the Canadian business and the impact of a £6.2 billion provision to settle litigation in the country after six years of legal proceedings.
Disclaimer: The author (Ian Conway) owns shares in British American Tobacco.
FULL-YEAR RESULTS
2 June: Sirius Real Estate
3 June: Pennon
4 June: B&M European Value Retail, Discoverie Group, Ninety One
5 June: CMC, Mitie, Wizz Air
FIRST-HALF RESULTS
3 June: Gooch & Housego
4 June: Paragon Banking, Ramsdens
5 June: Dr Martens
TRADING ANNOUNCEMENTS
3 June: British American Tobacco
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.